SCHEMBL5429402

SCHEMBL5429402

COc1ccc(CNC(=O)c2cccc(Oc3ccc(OCC(=O)O)c(C)c3)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 3/20 0.53
PPARD Q03181 4/20 0.52
PPARG P37231 3/20 0.52
PPARA Q07869 3/20 0.52
PDGFRB P09619 1/20 0.52
FLT4 P35916 1/20 0.52
KMT2A Q03164 2/20 0.50
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
MAPK14 Q16539 1/20 0.49
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
MEN1 O00255 1/20 0.48
USP2 O75604 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616353 0.89 PPARD (0.64) PPARDPPARGPPARAMAPK14
SCHEMBL4615804 0.84 PPARA (0.72) MMP13PPARDPPARGPPARA
SCHEMBL4616063 0.83 MMP13 (0.57) MMP13PDGFRBFLT4KMT2ASMN1; SMN2
SCHEMBL4616068 0.83 MMP13 (0.57) MMP13PDGFRBFLT4KMT2ANPC1
SCHEMBL4616524 0.82 PPARG (0.59) MMP13PPARDPPARGPPARANPC1
SCHEMBL4616100 0.80 TAS1R3 (0.48) PPARDPPARGPPARAHTTSMN1; SMN2
SCHEMBL9416562 0.80 MMP13 (0.76) MMP13PDGFRBFLT4KMT2ASMN1; SMN2
SCHEMBL4616034 0.80 PPARG (0.53) PPARDPPARGPPARAKMT2ASMN1; SMN2
SCHEMBL4616094 0.79 LPAR1 (0.55) PPARDPPARG
SCHEMBL5422973 0.78 FFAR1 (0.48) PPARDPPARGPPARASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697304-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2008-02-20 EP disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
EP-1697304-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2006-09-06 EP disclosed
WO-2005054176-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082907-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD MMP13 1797/4885PPARD 3/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.